Aromatherapy in Total Knee Replacement

NCT06045078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-01-27

No results posted yet for this study

Summary

The purpose of this pilot randomized controlled trial is to investigate the effects of aromatherapy on postoperative anxiety and pain in total knee replacement patients. The primary research questions are:

Does Lavender-Peppermint Aromatherapy reduce post operative anxiety in patients after primary total knee replacement when compared to placebo?

Does Lavender-Peppermint Aromatherapy reduce post operative pain in patient after primary total knee replacement when compared to placebo?

Participants will be assigned to one of the following groups at random:

* Intervention: Aromatherapy with the lavender-peppermint scent
* Control: Aromatherapy with the almond oil scent

Participants will also be asked to complete pre- and post-operative questionnaires.

Researchers will compare both groups (intervention vs control) to see if aromatherapy reduces post-operative anxiety and/or pain.

Conditions

  • Total Knee Replacement
  • Post-operative Nausea and Vomiting
  • Opioid Use
  • Anxiety
  • Depression
  • Post Operative Pain

Interventions

OTHER

Elequil Lavender-peppermint Aromatabs

100% pure essential oils Lavender-peppermint aromatabs purchased through Beekley Medical

OTHER

Elequil Almond-Oil Aromatabs

100% pure essential oils Almond-oil aromatabs purchased through Beekley Medical

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Uchenna Umeh, MD · Hospital for Special Surgery, New York

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06045078 on ClinicalTrials.gov